Catheter-Based Treatment of Coronary Artery Disease: Past, Present, and Future

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Circulation. Cardiovascular Interventions

• Publication date

  2008-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCINTERVENTIONS.108.783134PMID 20031656
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy

  2009cited by this paper
• CT coronary angiography of chronic total occlusions of the coronary arteries: how to recognize and evaluate and usefulness for planning percutaneous coronary interventions

  2009cited by this paper
• Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial.

  2008cited by this paper
• Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy

  2008cited by this paper
• Stents versus coronary-artery bypass grafting for left main coronary artery disease.

  2008cited by this paper
• Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease.

  2008cited by this paper
• Saphenous Vein Graft Stenting and Major Adverse Cardiac Events: A Predictive Model Derived From a Pooled Analysis of 3958 Patients

  2008cited by this paper
• A Comparison of Bare-Metal and Drug-Eluting Stents for Off-Label Indications

  2008cited by this paper
• A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease.

  2008cited by this paper
• Randomized comparison of cilostazol vs clopidogrel after drug-eluting stenting in diabetic patients--clilostazol for diabetic patients in drug-eluting stent (CIDES) trial.

  2008cited by this paper
• A comparison of bare-metal and drug-eluting stents for off-label indications.

  2008cited by this paper
• Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation.

  2008cited by this paper
• Twenty-Year Evolution of Percutaneous Coronary Intervention and Its Impact on Clinical Outcomes: A Report From the National Heart, Lung, and Blood Institute–Sponsored, Multicenter 1985–1986 PTCA and 1997–2006 Dynamic Registries

  2008cited by this paper
• Drug-Eluting Stent Update 2007: Part II: Unsettled Issues

  2007cited by this paper
• Platelet function monitoring in patients with coronary artery disease.

  2007cited by this paper
• Six-month clinical and angiographic results of a dedicated drug-eluting stent for the treatment of coronary bifurcation narrowings.

  2007cited by this paper
• Poor responsiveness to clopidogrel: drug-specific or class-effect mechanism? Evidence from a clopidogrel-to-ticlopidine crossover study.

  2007cited by this paper
• Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American D

  2007cited by this paper
• Thrombosis in Coronary Drug-Eluting Stents: Report From the Meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, December 7–8, 2006*

  2007cited by this paper
• Optimal medical therapy with or without PCI for stable coronary disease.

  2007cited by this paper
• Outcomes of Stent Thrombosis and Restenosis During Extended Follow-Up of Patients Treated With Bare-Metal Coronary Stents

  2007cited by this paper
• Thrombosis and drug-eluting stents: an objective appraisal.

  2007cited by this paper
• Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis.

  2007cited by this paper
• Trends in outcomes after percutaneous coronary intervention for chronic total occlusions: a 25-year experience from the Mayo Clinic.

  2007cited by this paper
• Pharmacologic approaches to restenosis prevention.

  2007cited by this paper
• Prasugrel versus clopidogrel in patients with acute coronary syndromes.

  2007cited by this paper
• Left main coronary artery stenosis: state-of-the-art.

  2007cited by this paper
• Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery

  2007cited by this paper
• Drug-eluting stents show delayed healing: paclitaxel more pronounced than sirolimus.

  2007cited by this paper
• Serial Angioscopic Evidence of Incomplete Neointimal Coverage After Sirolimus-Eluting Stent Implantation: Comparison With Bare-Metal Stents

  2007cited by this paper
• New antiplatelet therapies for acute coronary syndromes

  2007cited by this paper
• Stent thrombosis in randomized clinical trials of drug-eluting stents.

  2007cited by this paper
• Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis.

  2007cited by this paper
• Clinical ResearchInterventional CardiologyImpact of Stable Versus Unstable Coronary Artery Disease on 1-Year Outcome in Elective Patients Undergoing Multivessel Revascularization With Sirolimus-Eluting Stents: A Subanalysis of the ARTS II Trial

  2007cited by this paper
• Offsetting Impact of Thrombosis and Restenosis on the Occurrence of Death and Myocardial Infarction After Paclitaxel-Eluting and Bare Metal Stent Implantation

  2007cited by this paper
• The truth and consequences of the COURAGE trial.

  2007cited by this paper
• Pathological Correlates of Late Drug-Eluting Stent Thrombosis: Strut Coverage as a Marker of Endothelialization

  2007cited by this paper
• Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials.

  2007cited by this paper
• Optimizing platelet P2Y12 inhibition for patients undergoing PCI.

  2007cited by this paper
• Comparison of triple versus dual antiplatelet therapy after drug-eluting stent implantation (from the DECLARE-Long trial).

  2007cited by this paper
• Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.

  2006cited by this paper
• Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial.

  2006cited by this paper
• Impact of Completeness of Percutaneous Coronary Intervention Revascularization on Long-Term Outcomes in the Stent Era

  2006cited by this paper
• Myocardial infarction as a presentation of clinical in-stent restenosis.

  2006cited by this paper
• Drug-eluting coronary stents.

  2006cited by this paper
• Devices for distal protection during percutaneous coronary revascularization.

  2006cited by this paper
• Bare metal stent restenosis is not a benign clinical entity.

  2006cited by this paper
• Long-term Outcomes of Coronary-Artery Bypass Grafting Versus Stent Implantation

  2006cited by this paper
• The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase.

  2006cited by this paper
• Coronary-artery stents.

  2006cited by this paper
• Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase.

  2006cited by this paper
• Percutaneous Recanalization of Chronically Occluded Coronary Arteries: A Consensus Document Part II

  2005cited by this paper
• [Drug-eluting coronary stents].

  2005cited by this paper
• Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I.

  2005cited by this paper
• Variability in platelet responsiveness to clopidogrel among 544 individuals.

  2005cited by this paper
• Arterial Revascularisation Therapies Study Part II - Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions.

  2005cited by this paper
• Intracoronary brachytherapy--clinical state and pathophysiological considerations.

  2005cited by this paper
• Percutaneous coronary intervention for chronic total occlusions: the Thoraxcenter experience 1992-2002.

  2005cited by this paper
• One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials.

  2005cited by this paper
• Randomized Study to Evaluate Sirolimus-Eluting Stents Implanted at Coronary Bifurcation Lesions

  2004cited by this paper
• Sirolimus eluting stent implantation for patients with multivessel disease: rationale for the arterial revascularisation therapies study part II (ARTS II)

  2004cited by this paper
• Analysis of 1-Year Clinical Outcomes in the SIRIUS Trial: A Randomized Trial of a Sirolimus-Eluting Stent Versus a Standard Stent in Patients at High Risk for Coronary Restenosis

  2004cited by this paper
• Modeling and Risk Prediction in the Current Era of Interventional Cardiology: A Report From the National Heart, Lung, and Blood Institute Dynamic Registry

  2003cited by this paper
• Randomized Comparison of Distal Protection With a Filter-Based Catheter and a Balloon Occlusion and Aspiration System During Percutaneous Intervention of Diseased Saphenous Vein Aorto-Coronary Bypass Grafts

  2003cited by this paper
• Intracoronary brachytherapy for the prevention of restenosis after percutaneous coronary revascularization.

  2003cited by this paper
• Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) Trial

  2002cited by this paper
• Changes in the practice of percutaneous coronary intervention: a comparison of enrollment waves in the National Heart, Lung, and Blood Institute (NHLBI) Dynamic Registry.

  2001cited by this paper
• Point-of-Care Measured Platelet Inhibition Correlates With a Reduced Risk of an Adverse Cardiac Event After Percutaneous Coronary Intervention: Results of the GOLD (AU-Assessing Ultegra) Multicenter Study

  2001cited by this paper
• Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experience.

  2001cited by this paper
• Results of the study to determine rotablator and transluminal angioplasty strategy (STRATAS).

  2001cited by this paper
• Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experience.

  2001cited by this paper
• Immediate and one-year outcome in patients with coronary bifurcation lesions in the modern era (NHLBI dynamic registry).

  2001cited by this paper
• Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome.

  1999cited by this paper
• Balloon angioplasty versus new device intervention: clinical outcomes. A comparison of the NHLBI PTCA and NACI registries.

  1998cited by this paper
• ACC Expert Consensus document on coronary artery stents. Document of the American College of Cardiology.

  1998cited by this paper
• One-year follow-up in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT I)

  1995cited by this paper
• Six month outcome and determinants of adverse clinical events after successful excimer laser coronary angioplasty. ELCA A.I.S. Multicenter Registry.

  1995cited by this paper
• A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. CAVEAT-II Investigators.

  1995cited by this paper
• A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease

  1994cited by this paper
• A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators.

  1994cited by this paper
• A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group.

  1994cited by this paper
• Evaluating new devices. Acute (in-hospital) results from the New Approaches to Coronary Intervention Registry.

  1994cited by this paper
• Percutaneous excimer laser coronary angioplasty: Results in the first consecutive 3,000 patients

  1994cited by this paper
• Percutaneous excimer laser coronary angioplasty: results in the first consecutive 3,000 patients. The ELCA Investigators.

  1994cited by this paper
• Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy.

  1993cited by this paper
• National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry as a standard for comparison of new devices. When should we use it, and what should we compare?

  1991cited by this paper
• Comparison of complications during percutaneous transluminal coronary angioplasty from 1977 to 1981 and from 1985 to 1986: the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry.

  1988cited by this paper
• Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients.

  1988cited by this paper
• Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty.

  1987cited by this paper
• Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute.

  1984cited by this paper
• Follow-up of patients from the coronary artery surgery study (CASS) potentially suitable for percutaneous transluminal coronary angioplasty.

  1983cited by this paper
• Percutaneous transluminal coronary angioplasty: report from the Registry of the National Heart, Lung, and Blood Institute.

  1982cited by this paper
• Percutaneous transluminal coronary angioplasty: initial Mayo Clinic experience.

  1981cited by this paper
• Technique of percutaneous transluminal angioplasty with the Grüntzig ballon catheter.

  1979cited by this paper
• Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty.

  1979cited by this paper
• Transluminal dilatation of coronary-artery stenosis.

  1978cited by this paper
• Letter to the editor.

  1967cited by this paper
• The American Dental Association.

  1960cited by this paper

• Optimisation of Photo‐Curable 3D‐Printed Bionic Double Layer Lower Extremity Vascular Models Based on Biomechanical Performance Evaluation

  2025cites this paper
• The mechanism of influence of kaempferol on proline-rich acidic protein 1 (PRAP1) expression after percutaneous coronary intervention (PCI) was investigated based on sini decoction and siwu decoction

  2023cites this paper
• A Deep Multimodal Network for Classification and Identification of Interventionists' Hand Motions during Cyborg Intravascular Catheterization

  2021cites this paper
• Hardware Failure as a Rare Complication of Percutaneous Coronary Intervention: A Case Report

  2021cites this paper
• Percutaneous Intervention of CTO Lesion and Non-CTO Lesion in Patients with Coronary Chronic Total Occlusion

  2019cites this paper
• Decreased bed rest post‐percutaneous coronary intervention with a 7‐French arterial sheath and its effects on vascular complications

  2018cites this paper
• Utility of adjunctive modalities in Coronary chronic total occlusion intervention

  2017cites this paper
• Patients' health related quality of life after coronary revascularization : a longitudinal mixed method study

  2017cites this paper
• Trends in Patient Exposure to Radiation in Percutaneous Coronary Interventions Over a 10-Year Period.

  2017cites this paper
• Novel Looped-Catheter-Based 2D-3D Registration Algorithm for MR, 3DRx and X-Ray Images: Validation Study in an Ex-vivo Heart

  2016cites this paper
• Health-Related Quality of Life after Coronary Revascularization: A systematic review with meta-analysis.

  2016cites this paper
• Factors Associated with Early Adverse Events after Coronary Artery Bypass Grafting Subsequent to Percutaneous Coronary Intervention

  2016cites this paper
• Influence of Sex on Long-Term Outcomes After Implantation of Bare-Metal Stent: A Multicenter Report From the Coronary Revascularization Demonstrating Outcome Study-Kyoto (CREDO-Kyoto) Registry Cohort-1

  2015cites this paper
• Clinical Outcomes After Drug-Eluting Stents Versus Coronary Artery Bypass Surgery in High Surgical Risk Patients With Left Main or Three-Vessel Coronary Artery Disease

  2015cites this paper
• Percutaneous Coronary Intervention and the Various Coronary Artery Disease Syndromes

  2015cites this paper
• Promus Element™ Plus®A Drug‐Eluting Stent

  2015cites this paper
• 2D-3D registration of cardiac images

  2014cites this paper
• Rationale and design of a randomised clinical trial comparing vascular closure device and manual compression to achieve haemostasis after diagnostic coronary angiography: the Instrumental Sealing of ARterial puncture site - CLOSURE device versus manual compression (ISAR-CLOSURE) trial.

  2014cites this paper
• Vascular access and closure in coronary angiography and percutaneous intervention

  2013cites this paper
• Cyclic strain amplitude dictates the growth response of vascular smooth muscle cells in vitro: role in in-stent restenosis and inhibition with a sirolimus drug-eluting stent

  2013cites this paper
• Myocardial revascularization by percutaneous coronary intervention: past, present, and the future.

  2011cites this paper
• Left main intervention in myocardial infarction

  2010cites this paper
• PCI for critically ill STEMI patients with complex anatomy: Another (Nonrandomized) “Brick in the Wall”

  2009cites this paper
• CT coronary angiography of chronic total occlusions of the coronary arteries: how to recognize and evaluate and usefulness for planning percutaneous coronary interventions

  2009cites this paper
• Twenty-Year Evolution of Percutaneous Coronary Intervention and Its Impact on Clinical Outcomes: A Report From the National Heart, Lung, and Blood Institute–Sponsored, Multicenter 1985–1986 PTCA and 1997–2006 Dynamic Registries

  2008cites this paper